Back to Search

DANIELLE CUNNINGHAM, MD

MD

Radiation Oncology Physician

NPI: 1962997700IndividualAccepts Medicare

Specialties, Licenses & Credentials

Radiation Oncology PhysicianPrimary

Radiology — Radiation Oncology

Code: 2085R0001X

2018022145(MO)66139(MN)

CMS Specialties

PrimaryRADIATION ONCOLOGY

Education

UNIVERSITY OF MISSOURI, KANSAS CITY, SCHOOL OF MEDICINE

Class of 2018

Research & Publications (20)

Developmental expression pattern of the cholesterogenic enzyme NSDHL and negative selection of NSDHL-deficient cells in the heterozygous Bpa(1H)/+ mouse.
PMID 19631568·Mol Genet Metab·2009
7-preclinical
Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry.
PMID 19573860·Am J Ophthalmol·2009
4-observational
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
PMID 19497945·Ann Oncol·2009
8-other
Bevacizumab-associated gastrointestinal perforation.
PMID 19482241·Lancet Oncol·2009
8-other
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.
PMID 19474114·Ann Oncol·2009
1-meta
Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.
PMID 19470917·J Clin Oncol·2009
4-observational
Factors affecting plasmid production in Escherichia coli from a resource allocation standpoint.
PMID 19463175·Microb Cell Fact·2009
8-other
Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
PMID 19454457·Ann Oncol·2009
6-review
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.
PMID 19451425·J Clin Oncol·2009
3-trial
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
PMID 19450285·BMC Cancer·2009
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
200 1ST ST SW
ROCHESTER, MN 55905

Locations (2)

Practice Location

200 1ST ST SW, ROCHESTER, MN
(507) 284-2511

Practice Location

615 S NEW BALLAS RD, SAINT LOUIS, MO
(314) 509-5305

Quick Facts

NPI
1962997700
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
8
Publications
20

Are you this provider?

Claim Your Profile